This is what I wrote:
"... Charles River's toxicology data should be interesting in a few short weeks."
I am aware IND enabling takes of the order of months but the toxicology data/report by Chares Rivers should take weeks not months. Toxicology contributes to IND, which is in turn part of NDA.
Ann: Immutep granted US patent for IMP761 agonist LAG-3 antibody, page-18
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $1.240M | 3.112M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 27016 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 1649 | 2 |
View Market Depth
| Last trade - 15.59pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |